Delivery Order SPE2DB22D2206-SPE2DB24FHJ06

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,277.67 firm fixed-price delivery order contract has an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price contract is valued at $1,871.31 and has an ultimate completion date of November 22, 2024. It was awarded on November 21, 2024 as a delivery order, without any set-aside designation. AmerisourceBergen holds a significant $999,999,999...
The federal contract award detailed is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,435.52 with a firm fixed price and a completion date of December 18, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.54 firm fixed-price delivery order is for the supply of 4,567,299,271 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award is for the delivery of telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a ceiling value of $3,661.09 and a completion date of August 8, 2024. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Telmisartan 20 mg tablets. The $6,665.42 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the efficient procurement of a wide range of pharmaceutical products and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,915.95 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
This federal contract award is for the delivery of 4562941142 Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $1,556.19 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 29, 2023 with a completion date of November 30, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,751.57 for the delivery of Telmisartan 40 mg tablets. The contract has a period of performance through November 28, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen has established Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical and the...
This federal contract award is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $4,599.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHJ06
    Delivery Order

This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The $2,944.54 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 12:04 PM